... | ... | ... | Active substance | Medicinal product name | Pharmaceutical form | Strength | ATC code | Max. price range (€ incl. VAT) | ||
---|---|---|---|---|---|---|---|---|---|---|
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
NHS Reimbursed medicines |
Trastuzumabum | Herceptin | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) NHS Reimbursed medicines |
L01FD01 — ANTINEOPLASTIC AGENTS | € 650.73 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Trastuzumabum | Herceptin | Solution for injection | 600 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FD01 — ANTINEOPLASTIC AGENTS | € 1885.32 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Ontruzant | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | € 219.13 | skatīt informāciju par zālēm un iepakojumiem | |
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Ontruzant | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Herzuma | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | € 212.87 | skatīt informāciju par zālēm un iepakojumiem | |
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Herzuma | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Kanjinti | Powder for concentrate for solution for infusion | 150 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Kanjinti | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Trazimera | Powder for concentrate for solution for infusion | 150 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Trazimera | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Ogivri | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | € 212.87 | skatīt informāciju par zālēm un iepakojumiem | |
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Ogivri | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Zercepac | Powder for concentrate for solution for infusion | 150 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | € 212.87 | skatīt informāciju par zālēm un iepakojumiem | |
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Zercepac | Powder for concentrate for solution for infusion | 60 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | € 101.88 | skatīt informāciju par zālēm un iepakojumiem | |
Not available (according to the information provided by wholesalers) | Prescription (Pr.II onk. ķīm. ter.) | Trastuzumabum Biosimilar medicine |
Zercepac | Powder for concentrate for solution for infusion | 420 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II onk. ķīm. ter.) |
L01FD01 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Is available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) |
NHS Reimbursed medicines |
Trastuzumabum emtansinum | Kadcyla | Powder for concentrate for solution for infusion | 100 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II stac.) NHS Reimbursed medicines |
L01FD03 — ANTINEOPLASTIC AGENTS | € 2055.65 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) |
NHS Reimbursed medicines |
Trastuzumabum emtansinum | Kadcyla | Powder for concentrate for solution for infusion | 160 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II stac.) NHS Reimbursed medicines |
L01FD03 — ANTINEOPLASTIC AGENTS | € 3285.36 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) | Trastuzumabum deruxtecanum | Enhertu | Powder for concentrate for solution for infusion | 100 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FD04 — ANTINEOPLASTIC AGENTS | € 2172.62 | skatīt informāciju par zālēm un iepakojumiem | |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
NHS Reimbursed medicines |
Pertuzumabum, Trastuzumabum | Phesgo | Solution for injection | 1200 mg/600 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) NHS Reimbursed medicines |
L01FY01 — ANTINEOPLASTIC AGENTS | € 10288.60 | skatīt informāciju par zālēm un iepakojumiem |
Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
NHS Reimbursed medicines |
Pertuzumabum, Trastuzumabum | Phesgo | Solution for injection | 600 mg/600 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) NHS Reimbursed medicines |
L01FY01 — ANTINEOPLASTIC AGENTS | € 5840.45 | skatīt informāciju par zālēm un iepakojumiem |